Cost-Effectiveness of HPV vaccination; Need for Economic and Social Policy Intervention.
Mohammad Fakhrolmobasheri, Leila Mousavi Seresht
Author Information
- Mohammad Fakhrolmobasheri: Heart Failure Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran. ORCID
- Leila Mousavi Seresht: Department of Obstetrics and Gynecology, Isfahan University of Medical Sciences, Isfahan, Iran. ORCID
No abstract text available.
- Iran J Public Health. 2011;40(3):113-21
[PMID: 23113093]
- Virol J. 2010 Mar 22;7:65
[PMID: 20302680]
- Med Microbiol Immunol. 2017 Apr;206(2):105-110
[PMID: 27858157]
- CA Cancer J Clin. 2021 May;71(3):209-249
[PMID: 33538338]
- Lancet Public Health. 2021 Jul;6(7):e510-e521
[PMID: 33864738]
- Iran J Cancer Prev. 2011 Summer;4(3):135-40
[PMID: 26328053]
- Lancet Oncol. 2019 May;20(5):e238
[PMID: 31044713]
- Lancet Oncol. 2019 Mar;20(3):319-321
[PMID: 30795952]
- Value Health Reg Issues. 2018 May;15:112-119
[PMID: 29698864]
- J Oncol. 2019 Oct 10;2019:3257939
[PMID: 31687023]
- Int J Cancer. 2012 Jul 15;131(2):E156-61
[PMID: 22038830]
- Int J Infect Dis. 2021 Feb;103:480-488
[PMID: 33310023]
- Indian J Pathol Microbiol. 2010 Oct-Dec;53(4):681-5
[PMID: 21045392]
- Virol J. 2012 Sep 12;9:194
[PMID: 22967396]
Cost-Benefit Analysis
Female
Humans
Papillomavirus Infections
Papillomavirus Vaccines
Public Policy
Quality-Adjusted Life Years
Uterine Cervical Neoplasms
Vaccination
